- Conditions
- Degenerative Disc Disease, Spinal Stenosis
- Interventions
- OssDsign® Catalyst
- Device
- Lead sponsor
- OssDsign
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 450 participants
- Timeline
- 2022 – 2027
- U.S. locations
- 15
- States / cities
- Fresno, California • Long Beach, California • San Diego, California + 12 more
Source: ClinicalTrials.gov public record
Updated Apr 30, 2026 · Synced May 21, 2026, 8:07 PM EDT